A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in mice
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2059-0105
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in mice ; volume:7 ; number:1 ; day:22 ; month:7 ; year:2022 ; pages:1-13 ; date:12.2022
npj vaccines ; 7, Heft 1 (22.7.2022), 1-13, 12.2022
- Creator
-
Strohmeier, Shirin
Amanat, Fatima
Campbell, John D.
Traquina, Paula
Coffman, Robert L.
Krammer, Florian
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41541-022-00486-w
- URN
-
urn:nbn:de:101:1-2022100319580197125670
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Strohmeier, Shirin
- Amanat, Fatima
- Campbell, John D.
- Traquina, Paula
- Coffman, Robert L.
- Krammer, Florian
- SpringerLink (Online service)
Other Objects (12)
Adjuvanted infuenza vaccine dynamics
Adjuvanted influenza vaccine dynamics
II.1 Cpg 330, Cpg 338 und Cpg 389
Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay
CD16 CAR-T cells enhance antitumor activity of CpG ODN-loaded nanoparticle-adjuvanted tumor antigen-derived vaccinevia ADCC approach
Safety and efficacy of C. muridarum vaccines adjuvanted with CpG-1826 and four concentrations of Montanide-ISA-720-VG
III.1 Cpg 321 und Cpg 336
II.2 Cpg 98 und Cpg 366
I.1 Cpg 383 und Cpg 339
I.4 Cpg 315 und Cpg 340
A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
III.3 Cpg 395b und Cpg 341 Bl.241
Adjuvanted infuenza vaccine dynamics
Adjuvanted influenza vaccine dynamics
II.1 Cpg 330, Cpg 338 und Cpg 389
Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay
CD16 CAR-T cells enhance antitumor activity of CpG ODN-loaded nanoparticle-adjuvanted tumor antigen-derived vaccinevia ADCC approach
Safety and efficacy of C. muridarum vaccines adjuvanted with CpG-1826 and four concentrations of Montanide-ISA-720-VG
III.1 Cpg 321 und Cpg 336
II.2 Cpg 98 und Cpg 366
I.1 Cpg 383 und Cpg 339
I.4 Cpg 315 und Cpg 340
A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
III.3 Cpg 395b und Cpg 341 Bl.241
Adjuvanted infuenza vaccine dynamics
Adjuvanted influenza vaccine dynamics
II.1 Cpg 330, Cpg 338 und Cpg 389
Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay
CD16 CAR-T cells enhance antitumor activity of CpG ODN-loaded nanoparticle-adjuvanted tumor antigen-derived vaccinevia ADCC approach
Safety and efficacy of C. muridarum vaccines adjuvanted with CpG-1826 and four concentrations of Montanide-ISA-720-VG
III.1 Cpg 321 und Cpg 336
II.2 Cpg 98 und Cpg 366
I.1 Cpg 383 und Cpg 339
I.4 Cpg 315 und Cpg 340
A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines